Cancer remains top cause of death in Canada as some types rise

A new Canadian Medical Association Journal modelling study projects about 254,000 new cancer cases and nearly 88,000 cancer deaths in Canada in 2026, while projecting rises in cervical, head and neck, melanoma, pancreatic and uterine cancers.

Cancer remains the leading cause of death in Canada, according to a new modelling study published in the Canadian Medical Association Journal. The paper projects more than 254,000 new cancer cases and close to 88,000 cancer deaths in 2026. Researchers highlighted rising incidence for several cancer types even as overall age-standardized death rates are projected to fall. The article places these findings alongside existing vaccination and screening programs and notes ongoing policy discussions. Key findings: - The study projects more than 254,000 new cancer cases and nearly 88,000 cancer deaths in Canada in 2026. - Increases are projected for cervical cancer, head and neck cancers, melanoma, pancreatic cancer and uterine cancer. - Federal data cited in the report show HPV vaccination uptake in 2023 at about 76% for at least one dose and 67% for two doses among 14-year-olds, and the Canadian Cancer Society has called for a "once eligible, always eligible" vaccination policy. - Lung cancer is expected to remain the top cancer killer, accounting for roughly one in five cancer deaths (more than 19,000), and the study notes shifting patterns such as more cases among females and potential roles for exposures like radon and air pollution. - Colorectal cancer cases have fallen compared with the early 2000s but are rising in younger adults; most screening programs currently target ages 50 to 74, and Prince Edward Island has recently lowered its screening age to 45. Summary: The modelling underscores a sustained high cancer burden in Canada alongside mixed trends: some overall death rates are projected to decline while certain cancer types are rising. Advocacy groups and experts are urging policy responses on vaccination and screening, and some provincial adjustments have begun, but broader policy outcomes and their timing remain undetermined at this time.